Non ci sono recensioni
The nanotheranostics sector provides a very promising strategy for monitoring drug biodistribution and pathology longitudinal processes by integrating the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For its unique properties, which include their small size and biocompatibility and ability to permeate the cellular membrane with carrying drugs, nanomaterials have been used for various biomedical applications. This book covers the progress made in hormone-related cancer and their management by nonmedicinal therapy for targeting the hormone regulated cancer with their clinical progress and clinical hurdles.
Pages i-xiv
Pages 1-11
Pages 13-48
Pages 49-69
Pages 71-88
Pages 89-110
Pages 111-128
Pages 129-148
Pages 149-168
Pages 169-198
Pages 199-218
Pages 219-238
Pages 239-252
Pages 253-267
Pages 269-297
Pages 299-310
Pages 311-324
Pages 325-347
Sei sicuro di voler eseguire questa azione?